DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
O•••••• T••••••••• P••
Healthcare & Pharmaceuticalsgroup grade Aoff every schedule since Dec 31, 2023sponsor unattributed
Also written as: Undrawn Commitment
Nothing material in the last 200 days. Last change: 31 Dec 2023, Consensus mark 106¢ on cost, up from 101¢ in Q4 2022, 100¢ last quarter.
Mark path, consensus per quarter end
101¢ · 100¢ · 100¢ · 106¢Q4 2022 to Q4 2023
Principal held
at least $7.6M
sum of BDC pieces, a lower bound
Fair value
$8.0M
106c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
1 equity pieces beside them
Next maturity
May 28, 2026
no dated debt inside 24 months
On the tape since
Mar 31, 2022
latest Dec 31, 2023
Events
2
dated, non-routine
Lender marks
each lender's own fair value over cost at Dec 31, 2023, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| M••••• F•••••••• I••••••••• C••• | $7.6M | 106¢ | +6 pts |
Every BDC piece · 1 position across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| M••••• F•••••••• I••••••••• C••• | term loan first lien F•••• L••• S•••••• D••• S•••+605, 1.00% F•••• M••••••• D••• 05/28/26 | $7.6M | $8.0M 106c | S+605 bp |
Capital structure as the BDCs see it
latest quarter end Dec 31, 2023
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Dec 31, 2023 | at least $7.6M | 106c | S+605 bp | May 28, 2026 | 1 |
Equity pieces beside the debt: other (Not disclosed fair value, 1 BDC)
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Dec 31, 2023 | 1 | $7.6M | $8.0M | 106c | 0 |
| Sep 30, 2023 | 1 | $8.4M | $8.4M | 100c | 0 |
| Jun 30, 2023 | 1 | $9.2M | $9.2M | 100c | 0 |
| Mar 31, 2023 | 1 | $10.0M | $10.0M | n/a | 0 |
All 6 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Dec 31, 2022 | 1 | $66.1M | $21.6M | 202c | 0 |
| Mar 31, 2022 | 1 | $0 | $0 | n/a | 0 |
What changed
- Facility left every BDC scheduleDec 31, 2023
- New borrower on a BDC scheduleMar 31, 2022
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- O•••••• T•••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it